Skip to content

Mannkind MNKD Other income, net (Note 6)

Other income, net (Note 6) at other companies

Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$1.54M-30.5%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$5K+267%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$2.44M-102%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$5.8M-41.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$12.02M+4,145%
Tenet Healthcare logo
Tenet HealthcareTHC

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/E228.5×
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Mannkind’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's other income, net (note 6)?
Mannkind (MNKD) reported other income, net (note 6) of -$2.78M in Q1 2026.
How has Mannkind's other income, net (note 6) changed year-over-year?
Mannkind's other income, net (note 6) decreased by 1000.9% year-over-year, from -$252.25K to -$2.78M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.